Section 1: Gene Identifiers
Primary Gene Identifiers
| Database | Identifier | Notes |
|---|
| HGNC ID | HGNC:11892 | Approved |
| HGNC Symbol | TNF | Approved symbol |
| Ensembl Gene | ENSG00000232810 | Human |
| NCBI Entrez Gene | 7124 | Human |
| OMIM | 191160 | Gene/Locus |
Gene Names and Aliases
- Approved Name: tumor necrosis factor
- Previous Name: tumor necrosis factor (TNF superfamily, member 2)
- Aliases: TNFSF2, DIF, TNF-alpha, TNFA, TNLG1F, IMD127
- Previous Symbol: TNFA
- Locus Group: protein-coding gene
- Gene Group: Tumor necrosis factor superfamily
Genomic Location
| Feature | Value |
|---|
| Chromosome | 6 |
| Cytogenetic Band | 6p21.33 |
| Start Position | 31,575,565 (GRCh38) |
| End Position | 31,578,336 (GRCh38) |
| Strand | + (positive) |
| Genomic Accession | NC_000006.12 |
| Gene Length | 2,772 bp |
Gene Summary
This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus
functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation,
differentiation, apoptosis, lipid metabolism, and coagulation.
Section 2: Transcript Identifiers
Ensembl Transcripts
Total Transcript Count: 2
| Transcript ID | Biotype | Start | End | Strand | 5'UTR | 3'UTR |
|---|
| ENST00000449264 ★ | protein_coding | 31,575,565 | 31,578,336 | + | 31,575,565-31,575,741 | 31,577,538-31,578,336 |
| ENST00000699334 | protein_coding | 31,575,742 | 31,577,537 | + | - | 31,577,116-31,577,537 |
★ = Canonical transcript
RefSeq Transcripts (Human)
Total: 2 Human mRNA transcripts
| RefSeq ID | Symbol | Type | Status | MANE Select |
|---|
| NM_000594 ★ | TNF | mRNA | REVIEWED | Yes |
| (Alternative transcripts from related genes also mapped) | | | | |
★ = MANE Select / Canonical clinical standard
CCDS Identifiers
| CCDS ID | Notes |
|---|
| CCDS4702 | Consensus coding sequence |
Exon Information (Canonical Transcript ENST00000449264)
Total Exon Count: 4
| Exon ID | Start | End | Strand | Chromosome |
|---|
| ENSE00001939157 | 31,575,565 | 31,575,927 | + | 6 |
| ENSE00001610044 | 31,576,534 | 31,576,579 | + | 6 |
| ENSE00001691672 | 31,576,767 | 31,576,814 | + | 6 |
| ENSE00001933375 | 31,577,116 | 31,578,336 | + | 6 |
Section 3: Protein Identifiers
UniProt Accessions
| UniProt ID | Name | Status | Length | Mass |
|---|
| P01375 ★ | Tumor necrosis factor | Reviewed (Swiss-Prot) | 233 aa | 25,644 Da |
★ = Canonical reviewed entry
Alternative Names:
- Cachectin
- TNF-alpha
- Tumor necrosis factor ligand superfamily member 2
RefSeq Protein Accessions (Human)
| RefSeq Protein | Symbol | Status | MANE Select |
|---|
| NP_000585 ★ | TNF | REVIEWED | Yes |
Protein Domains and Families
Total Domain Annotations: 5
| InterPro ID | Name | Type |
|---|
| IPR002959 | TNF_alpha | Family |
| IPR006052 | TNF_dom | Domain |
| IPR006053 | TNF | Family |
| IPR008983 | Tumour_necrosis_fac-like_dom | Homologous Superfamily |
| IPR021184 | TNF_CS | Conserved Site |
Section 4: Structure Identifiers
Experimental Structures (PDB)
Total PDB Structure Count: 50
| PDB ID | Title | Method | Resolution (Å) |
|---|
| 9OJO | TNF alpha in complex with compound 1 | X-ray | 1.358 |
| 5UUI | Spin-Labeled T77C TNFa | X-ray | 1.4 |
| 4Y6O | SIRT2 with myristoylated TNF-alpha peptide | X-ray | 1.6 |
| 2E7A | TNFR1-selective TNF Mutant | X-ray | 1.8 |
| 4TSV | Human TNF-alpha mutant (high resolution) | X-ray | 1.8 |
| 9OJS | TNF alpha in complex with compound 4 | X-ray | 1.849 |
| 5M2J | TNF alpha with Llama VHH2 | X-ray | 1.9 |
| 9BN7 | TNFa-VNAR C4 complex | X-ray | 1.92 |
| 2AZ5 | TNF-alpha with small molecule inhibitor | X-ray | 2.1 |
| 3L9J | TNFalpha with antagonist | X-ray | 2.1 |
| 7JRA | TNF-ALPHA with quinoline compound | X-ray | 2.1 |
| 5M2I | TNF with Llama VHH1 | X-ray | 2.15 |
| 7KP9 | Asymmetric hTNF-alpha | X-ray | 2.15 |
| 9OJY | TNF alpha with compound 3 | X-ray | 2.158 |
| 1A8M | TNF-alpha R31D mutant | X-ray | 2.3 |
| 5M2M | TNF alpha with Llama VHH3 | X-ray | 2.3 |
| 7KPA | Asymmetric hTNF-alpha | X-ray | 2.3 |
| 2ZJC | TNFR1 selective TNF mutant R1-6 | X-ray | 2.5 |
| 6OOY | Asymmetric hTNF-alpha | X-ray | 2.5 |
| 5TSW | Human TNF-alpha mutant | X-ray | 2.5 |
| 7TA3 | TNF-alpha with alpha-peptide-3 | X-ray | 2.5 |
| 6OP0 | Asymmetric hTNF-alpha | X-ray | 2.55 |
| 8ZUI | TNF-TNFR1 ectodomain complex | Cryo-EM | 2.56 |
| 8Z8M | TNF alpha with ozoralizumab VHH domain | X-ray | 2.59 |
| 4G3Y | TNF-alpha with Infliximab Fab | X-ray | 2.6 |
| 1TNF | TNF-alpha structure (classic) | X-ray | 2.6 |
| 6RMJ | Human NGR-TNF | X-ray | 2.65 |
| 7TA6 | TNF-alpha with alpha/beta-peptide-1 | X-ray | 2.67 |
| 5YOY | TNF with golimumab Fv | X-ray | 2.727 |
| 9OK6 | TNF alpha with compound 19 | X-ray | 2.776 |
| 3IT8 | TNF alpha with poxvirus TNF binding protein | X-ray | 2.8 |
| 6OOZ | Asymmetric hTNF-alpha | X-ray | 2.8 |
| 6X81 | TNFalpha with isoquinoline compound 2 | X-ray | 2.81 |
| 2ZPX | TNFR1-selective TNF mutant R1antTNF-T8 | X-ray | 2.83 |
| 6X83 | TNFalpha with fragment compound 6 | X-ray | 2.83 |
| 4TWT | TNFa dimer with bicyclic peptide M21 | X-ray | 2.85 |
| 6X85 | TNFalpha with indolinone compound 9 | X-ray | 2.85 |
| 5WUX | TNFalpha-certolizumab Fab | X-ray | 2.9 |
| 6X86 | TNFalpha with indolinone compound 11 | X-ray | 2.93 |
| 3ALQ | TNF-TNFR2 complex | X-ray | 3.0 |
| 5MU8 | TNF-ALPHA with JNJ525 | X-ray | 3.0 |
| 7KPB | TNF-TNFR1 with antibody | X-ray | 3.0 |
| 2TUN | TNF-alpha Ala-84-Val mutant | X-ray | 3.1 |
| 3WD5 | TNFalpha with Adalimumab Fab | X-ray | 3.101 |
| 9DJW | TNFa-VNAR D1 complex | X-ray | 3.43 |
| 7ASY | TNF-alpha transmembrane helix | NMR | - |
| 7AT7 | TNF-alpha TM helix S34P mutant | NMR | - |
| 7ATB | TNF-alpha TM helix AGALLL mutant | NMR | - |
| 7QLF | Solnatide conformational ensemble | NMR | - |
AlphaFold Predicted Structure
| AlphaFold ID | Global pLDDT | Sequence Length | Fraction Very High Confidence |
|---|
| P01375 | 84.72 | 1,808 | 0.63 (63%) |
Section 5: Cross-Species Orthologs
Orthologs in Key Model Organisms
| Species | Gene ID | Symbol | Chromosome | Position |
|---|
| Mouse (Mus musculus) | ENSMUSG00000024401 | Tnf | 17 | 35,418,357-35,420,983 (-) |
| Rat (Rattus norvegicus) | ENSRNOG00000070745 | Tnf | 20 | 3,626,532-3,629,303 (+) |
| Zebrafish (Danio rerio) | 554167 (Entrez) | tnfa/tnfb | - | - |
| Fruit fly (Drosophila) | 36054 (Entrez) | eiger | - | (Functional homolog) |
| Worm (C. elegans) | No direct ortholog | - | - | - |
| Yeast (S. cerevisiae) | No ortholog | - | - | - |
Note: TNF is a vertebrate-specific cytokine. Invertebrates like Drosophila have functional analogs (eiger) but not true orthologs.
Section 6: Clinical Variants & AI Predictions
ClinVar Variant Annotations
Total Variant Count: 26
Breakdown by Classification:
| Classification | Count |
|---|
| Pathogenic | 3 |
| Likely Pathogenic | 0 |
| Uncertain Significance (VUS) | 11 |
| Likely Benign | 4 |
| Benign | 2 |
| Risk Factor | 2 |
| Protective | 1 |
| Drug Response | 1 |
| Not Provided | 2 |
Pathogenic/Likely Pathogenic Variants:
| ClinVar ID | Variant | HGVS | Classification | Review Status |
|---|
| 12385 | L29S | L29S | Pathogenic | no assertion criteria |
| 12386 | R108W | NM_000594.4(TNF):c.322C>T (p.Arg108Trp) | Pathogenic | no assertion criteria |
| 3362893 | 20-BP INS | TNF, 20-BP INS, NT190 | Pathogenic | no assertion criteria |
Risk Factor/Drug Response Variants:
| ClinVar ID | Variant | Classification |
|---|
| 12387 | g.31575186G>A | Risk factor |
| 12389 | g.31574705C>T | Risk factor |
| 12390 | g.31574699C>A | Protective |
| 225964 | g.31575254G>A | Drug response (expert reviewed) |
SpliceAI Predictions
Total Predicted Splice-Altering Variants: 205
TOP 50 High-Impact Splice Predictions (Score ≥ 0.9):
| Variant | Effect | Delta Score |
|---|
| 6:31575924:AGAG:A | donor_gain | 1.00 |
| 6:31575924:AGAGG:A | donor_loss | 1.00 |
| 6:31575925:GAG:G | donor_gain | 1.00 |
| 6:31575925:GAGG:G | donor_gain | 1.00 |
| 6:31575925:GAGGT:G | donor_loss | 1.00 |
| 6:31575926:AG:A | donor_gain | 1.00 |
| 6:31575927:GG:G | donor_gain | 1.00 |
| 6:31575927:GGTG:G | donor_loss | 1.00 |
| 6:31575928:G:GG | donor_gain | 1.00 |
| 6:31576532:A:AG | acceptor_gain | 1.00 |
| 6:31576533:G:GG | acceptor_gain | 1.00 |
| 6:31576576:GTCA:G | donor_gain | 1.00 |
| 6:31576580:G:GG | donor_gain | 1.00 |
| 6:31575922:G:T | donor_gain | 0.99 |
| 6:31575923:AAGAG:A | donor_gain | 0.99 |
| 6:31576530:ACAGT:A | acceptor_loss | 0.99 |
| 6:31576532:A:C | acceptor_loss | 0.99 |
| 6:31576533:GT:G | acceptor_gain | 0.99 |
| 6:31576533:GTT:G | acceptor_gain | 0.99 |
| 6:31576533:GTTC:G | acceptor_gain | 0.99 |
| 6:31576533:GTTCC:G | acceptor_gain | 0.99 |
AlphaMissense Predictions
Total Missense Predictions: 1,498
TOP 50 Predicted Pathogenic Missense Variants:
| Variant | Protein Change | AM Score | Classification |
|---|
| 6:31575745:A:C | S2R | 0.913 | likely_pathogenic |
| 6:31575746:G:T | S2I | 0.853 | likely_pathogenic |
| 6:31575761:T:C | I7T | 0.906 | likely_pathogenic |
| 6:31575761:T:G | I7S | 0.844 | likely_pathogenic |
| 6:31575759:G:A | M6I | 0.836 | likely_pathogenic |
| 6:31575758:T:C | M6T | 0.758 | likely_pathogenic |
| 6:31575761:T:A | I7N | 0.770 | likely_pathogenic |
| 6:31575766:G:C | D9H | 0.765 | likely_pathogenic |
| 6:31575767:A:T | D9V | 0.737 | likely_pathogenic |
| 6:31575767:A:C | D9A | 0.680 | likely_pathogenic |
| 6:31575749:C:T | T3I | 0.673 | likely_pathogenic |
| 6:31575774:G:C | E11D | 0.655 | likely_pathogenic |
| 6:31575758:T:A | M6K | 0.645 | likely_pathogenic |
| 6:31575745:A:T | S2C | 0.629 | likely_pathogenic |
| 6:31575758:T:G | M6R | 0.622 | likely_pathogenic |
| 6:31575766:G:A | D9N | 0.622 | likely_pathogenic |
| 6:31575768:C:A | D9E | 0.617 | likely_pathogenic |
| 6:31575772:G:A | E11K | 0.610 | likely_pathogenic |
| 6:31575767:A:G | D9G | 0.606 | likely_pathogenic |
| 6:31575773:A:T | E11V | 0.595 | likely_pathogenic |
| 6:31575752:A:T | E4V | 0.589 | likely_pathogenic |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways
Total Pathway Count: 10
| Pathway ID | Pathway Name |
|---|
| R-HSA-75893 | TNF signaling |
| R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway |
| R-HSA-5357786 | TNFR1-induced proapoptotic signaling |
| R-HSA-5357905 | Regulation of TNFR1 signaling |
| R-HSA-5626978 | TNFR1-mediated ceramide production |
| R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway |
| R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation |
| R-HSA-6783783 | Interleukin-10 signaling |
| R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling |
| R-HSA-9942503 | Differentiation of naive CD+ T cells to Th1 cells |
Gene Ontology Annotations
Total GO Annotations: 193
Biological Process (TOP 20 of ~150)
| GO ID | Term |
|---|
| GO:0006954 | inflammatory response |
| GO:0006955 | immune response |
| GO:0033209 | tumor necrosis factor-mediated signaling pathway |
| GO:0007249 | canonical NF-kappaB signal transduction |
| GO:0043065 | positive regulation of apoptotic process |
| GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0045944 | positive regulation of transcription by RNA polymerase II |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
| GO:0043507 | positive regulation of JUN kinase activity |
| GO:0050729 | positive regulation of inflammatory response |
| GO:0031622 | positive regulation of fever generation |
| GO:0030316 | osteoclast differentiation |
| GO:0032755 | positive regulation of interleukin-6 production |
| GO:0032731 | positive regulation of interleukin-1 beta production |
| GO:0043123 | positive regulation of canonical NF-kappaB signal transduction |
| GO:0001774 | microglial cell activation |
| GO:0002281 | macrophage activation involved in immune response |
| GO:0045672 | positive regulation of osteoclast differentiation |
| GO:0048661 | positive regulation of smooth muscle cell proliferation |
| GO:0097527 | necroptotic signaling pathway |
Molecular Function (TOP 20 of ~15)
| GO ID | Term |
|---|
| GO:0005125 | cytokine activity |
| GO:0005164 | tumor necrosis factor receptor binding |
| GO:0048018 | receptor ligand activity |
| GO:0038177 | death receptor agonist activity |
| GO:0042802 | identical protein binding |
| GO:0002020 | protease binding |
| GO:0000976 | transcription cis-regulatory region binding |
| GO:0140072 | histone H3K9ac reader activity |
Cellular Component (TOP 20 of ~15)
| GO ID | Term |
|---|
| GO:0005576 | extracellular region |
| GO:0005615 | extracellular space |
| GO:0005886 | plasma membrane |
| GO:0009986 | cell surface |
| GO:0009897 | external side of plasma membrane |
| GO:0045121 | membrane raft |
| GO:0001891 | phagocytic cup |
| GO:0043025 | neuronal cell body |
| GO:0055037 | recycling endosome |
Section 8: Protein Interactions & Molecular Networks
Protein-Protein Interactions (STRING)
Total Interaction Count: 10,273+
TOP 50 Highest-Confidence Interacting Proteins:
| UniProt ID | Gene | Score | Description |
|---|
| P19438 | TNFRSF1A | 999 | TNF receptor superfamily member 1A |
| P20333 | TNFRSF1B | 998 | TNF receptor superfamily member 1B |
| O00220 | TNFRSF10A | 997 | TNF receptor superfamily member 10A (TRAIL-R1) |
| O14763 | TNFRSF10B | 997 | TNF receptor superfamily member 10B (TRAIL-R2) |
| P25445 | FAS | 997 | Fas cell surface death receptor |
| P14778 | IL1R1 | 996 | Interleukin 1 receptor type 1 |
| Q15628 | TRADD | 996 | TNFRSF1A associated via death domain |
| P19838 | NFKB1 | 995 | Nuclear factor kappa B subunit 1 |
| Q9Y4K3 | TRAF6 | 995 | TNF receptor associated factor 6 |
| P01584 | IL1B | 993 | Interleukin 1 beta |
| P01579 | IFNG | 990 | Interferon gamma |
| P05231 | IL6 | 989 | Interleukin 6 |
| P78507 | EDN1 | 987 | Endothelin 1 |
| P22301 | IL10 | 984 | Interleukin 10 |
| P25942 | CD40 | 984 | CD40 molecule |
| P48023 | FASLG | 984 | Fas ligand |
| P08887 | IL6R | 977 | Interleukin 6 receptor |
| P01583 | IL1A | 976 | Interleukin 1 alpha |
| Q13158 | FADD | 973 | Fas associated via death domain |
| P02751 | FN1 | 970 | Fibronectin 1 |
| O00206 | TLR4 | 966 | Toll like receptor 4 |
| P01730 | CD4 | 966 | CD4 molecule |
| P10145 | CXCL8 | 965 | C-X-C motif chemokine ligand 8 (IL-8) |
| P05112 | IL4 | 963 | Interleukin 4 |
| P01732 | CD8A | 957 | CD8a molecule |
| Q16552 | IL17A | 957 | Interleukin 17A |
| P01585 | IL2 | 956 | Interleukin 2 |
| P13500 | CCL2 | 953 | C-C motif chemokine ligand 2 |
| P50591 | TNFSF10 | 944 | TNF superfamily member 10 (TRAIL) |
| Q04206 | RELA | 944 | RELA proto-oncogene, NF-kB subunit |
| O60603 | TLR2 | 943 | Toll like receptor 2 |
| Q13546 | RIPK1 | 943 | Receptor interacting serine/threonine kinase 1 |
| P02741 | CRP | 938 | C-reactive protein |
| P25963 | NFKBIA | 937 | NF-kappa-B inhibitor alpha |
| Q14116 | IL18 | 937 | Interleukin 18 |
| P01137 | TGFB1 | 936 | Transforming growth factor beta 1 |
| O14920 | IKBKB | 934 | Inhibitor of NF-kappa B kinase subunit beta |
| P78397 | STING1 | 933 | Stimulator of interferon genes |
| P42574 | CASP3 | 932 | Caspase 3 |
| P35225 | IL13 | 931 | Interleukin 13 |
| P02778 | CXCL10 | 930 | C-X-C motif chemokine ligand 10 |
| P04141 | CSF2 | 930 | Colony stimulating factor 2 |
| P05113 | IL5 | 930 | Interleukin 5 |
| P05362 | ICAM1 | 929 | Intercellular adhesion molecule 1 |
| Q14790 | CASP8 | 929 | Caspase 8 |
| P01308 | INS | 927 | Insulin |
| P10147 | CCL3 | 924 | C-C motif chemokine ligand 3 |
| P13501 | CCL5 | 924 | C-C motif chemokine ligand 5 |
| P01562 | IFNA1 | 923 | Interferon alpha 1 |
| P27361 | MAPK3 | 921 | Mitogen-activated protein kinase 3 |
IntAct Molecular Interactions
Total IntAct Interaction Count: 212
Key high-confidence interactions (score ≥ 0.9):
- TNF ↔ TNFRSF1A (score: 0.96)
- TNF ↔ TRADD (score: 0.79)
- TNF ↔ TNF (homotrimer, score: 0.73)
CellPhoneDB Ligand-Receptor Pairs
| Interaction ID | Partner A | Partner B | Classification |
|---|
| CPI-SS04B4619D0 | TNF (P01375) | TNFRSF1A (P19438) | Ligand-Receptor |
| CPI-SS0E7D5974D | TNF (P01375) | TNFRSF1B (P20333) | Ligand-Receptor |
Protein Similarity
ESM2 Structural Similarity
Total Similar Proteins: 77
TOP 20 by ESM2 embedding similarity:
| UniProt ID | Similarity Count | Top Similarity | Avg Similarity |
|---|
| P59684 | 50 | 1.000 | 0.994 |
| P59693 | 50 | 1.000 | 0.994 |
| P59694 | 50 | 1.000 | 0.995 |
| P63182 | 50 | 1.000 | 0.973 |
| P63306 | 50 | 1.000 | 0.987 |
| P63307 | 50 | 1.000 | 0.987 |
| P63308 | 50 | 1.000 | 0.987 |
| P86437 | 50 | 1.000 | 0.973 |
| Q06599 | 50 | 1.000 | 0.994 |
| Q2MH05 | 50 | 1.000 | 0.994 |
| Q75N23 | 50 | 1.000 | 0.995 |
DIAMOND Sequence Homology
Total Homologous Proteins: 54
TOP 20 by sequence identity:
| UniProt ID | Identity (%) | Bitscore | Description |
|---|
| P59684 | 100.0 | 472 | TNF (Macaca mulatta) |
| Q06599 | 100.0 | 472 | TNF (Chlorocebus aethiops) |
| Q2MH05 | 100.0 | 472 | TNF (Pan troglodytes) |
| P63306 | 100.0 | 509 | TNF (Bos taurus) |
| P63307 | 100.0 | 509 | TNF (Capra hircus) |
| P63308 | 100.0 | 509 | TNF (Ovis aries) |
| O77510 | 99.6 | 466 | TNF (Macaca fascicularis) |
| P59694 | 99.6 | 466 | TNF (Hylobates lar) |
| Q75N23 | 99.6 | 466 | TNF (Gorilla gorilla) |
| P01374 | 99.5 | 407 | LTA (Homo sapiens, lymphotoxin-alpha) |
| P61125 | 99.5 | 407 | LTA (Pan troglodytes) |
| P48094 | 99.6 | 466 | TNF (Pongo pygmaeus) |
| P33620 | 98.3 | 456 | TNF (Canis lupus familiaris) |
| Q8WNR1 | 98.3 | 454 | TNF (Felis catus) |
| Q9BEA1 | 98.3 | 453 | TNF (Sus scrofa) |
| P13296 | 97.9 | 461 | TNF (Oryctolagus cuniculus) |
| P23383 | 97.9 | 461 | TNF (Equus caballus) |
Section 9: Transcription Factor Regulatory Data
Note: TNF is not a transcription factor itself, but is regulated by numerous transcription factors.
Upstream Regulators (TFs that Regulate TNF)
Total Upstream Regulators: 248 (from CollecTRI)
TOP 50 Transcription Factors Regulating TNF:
| TF Gene | Regulation | Confidence |
|---|
| NFKB1/RELA (NfKb-p65/p50) | Activation | High |
| JUN | Activation | High |
| FOS | Activation | High |
| AP1 | Activation | High |
| CREB1 | Activation | High |
| ATF2 | Activation | High |
| ATF3 | Activation | High |
| EGR1 | Activation | High |
| ELK1 | Activation | High |
| ETS1 | Activation | High |
| IRF1 | Activation | High |
| IRF3 | Activation | High |
| IRF8 | Activation | High |
| HIF1A | Activation | High |
| FOXO1 | Activation | High |
| BCL3 | Activation | High |
| LITAF | Activation | High |
| JUND | Activation | High |
| FOSB | Activation | High |
| JUNB | Activation | Low |
| ESR1 | Activation | High |
| AHR | Activation | High |
| CREM | Activation | High |
| SP1 | Activation | High |
| CEBPB | Unknown | High |
| CEBPD | Unknown | High |
| CTCF | - | High |
| DNMT1 | - | High |
| HSF1 | Unknown | High |
| KLF4 | Repression | - |
| CEBPA | Repression | - |
| EZH2 | Repression | - |
| HDAC11 | Repression | - |
| FUBP1 | Repression | Low |
| LRRFIP1 | Repression | High |
| APP | Repression | - |
| MFGE8 | Repression | - |
SIGNOR Regulatory Relationships
Total SIGNOR Entries: 100+
Key regulatory interactions involving TNF:
| Source | Target | Effect | Mechanism |
|---|
| ADAM17 | TNF | up-regulates | cleavage |
| SIRT6 | TNF | up-regulates | deacetylation |
| IRF5 | TNF | up-regulates | transcriptional |
| NfKb-p65/p50 | TNF | up-regulates | transcriptional |
| IL1A | TNF | up-regulates | transcriptional |
| KLF4 | TNF | down-regulates | transcriptional |
| FUBP1 | TNF | down-regulates | transcriptional |
| MFGE8 | TNF | down-regulates | transcriptional |
Section 10: Drug & Pharmacology Data
ChEMBL Target
| ChEMBL Target ID | Name | Type |
|---|
| CHEMBL1825 | Tumor necrosis factor | SINGLE PROTEIN |
Approved and Late-Stage Drugs Targeting TNF
Drugs with Development Phase ≥3: 7
| ChEMBL ID | Drug Name | Type | Highest Phase | Mechanism |
|---|
| CHEMBL131 | PREDNISOLONE | Small molecule | 4 (Approved) | Glucocorticoid |
| CHEMBL628 | PENTOXIFYLLINE | Small molecule | 4 (Approved) | Phosphodiesterase inhibitor |
| CHEMBL704 | MESALAMINE | Small molecule | 4 (Approved) | Anti-inflammatory |
| CHEMBL848 | LENALIDOMIDE | Small molecule | 4 (Approved) | Immunomodulator |
| CHEMBL43452 | POMALIDOMIDE | Small molecule | 4 (Approved) | Immunomodulator |
| CHEMBL279785 | MARIMASTAT | Small molecule | 3 | MMP inhibitor |
| CHEMBL3989927 | IBERDOMIDE | Small molecule | 3 | Immunomodulator |
Biologic TNF Inhibitors (from SIGNOR)
| Drug | Mechanism | Type |
|---|
| Infliximab (Remicade) | TNF binding/neutralization | Monoclonal antibody |
| Etanercept (Enbrel) | TNF binding/neutralization | Fusion protein |
| Adalimumab (Humira) | TNF binding/neutralization | Monoclonal antibody |
| Golimumab (Simponi) | TNF binding/neutralization | Monoclonal antibody |
| Certolizumab (Cimzia) | TNF binding/neutralization | PEGylated Fab |
| Doramapimod | MAPK14/p38 inhibition | Small molecule |
PharmGKB Drug-Gene Interactions
PharmGKB Gene ID: PA435 (VIP Gene = Yes)
Total Associated Drugs: 32
| Drug | Clinical Annotations | Variant Annotations |
|---|
| Carbamazepine | 52 | 403 |
| Cyclosporine | 26 | 157 |
| Rifampin | 24 | 182 |
| Isoniazid | 23 | 237 |
| Infliximab | 21 | 128 |
| Mycophenolate mofetil | 20 | 99 |
| Tenofovir | 17 | 109 |
| Sirolimus | 14 | 44 |
| Sufentanil | 12 | 68 |
| Rituximab | 10 | 55 |
| Pyrazinamide | 9 | 130 |
| Ethambutol | 8 | 130 |
| Ibuprofen | 8 | 46 |
| Sumatriptan | 8 | 29 |
| Diclofenac | 7 | 53 |
| Omeprazole | 5 | 183 |
| Glucocorticoids (class) | 48 | 203 |
| Certolizumab pegol | 4 | 15 |
Section 11: Expression Profiles
Bgee Expression Summary
| Metric | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 119 |
| Max Expression Score | 96.17 |
Tissue Expression (TOP 30)
| Rank | Tissue/Cell Type | Expression Score | Quality |
|---|
| 1 | Granulocyte | 96.17 | Gold |
| 2 | Male germ line stem cell (testis) | 87.11 | Gold |
| 3 | Bone marrow | 86.37 | Gold |
| 4 | Leukocyte | 85.79 | Gold |
| 5 | Monocyte | 85.61 | Gold |
| 6 | Bone marrow cell | 84.38 | Gold |
| 7 | Blood | 77.44 | Gold |
| 8 | Lymph node | 77.13 | Gold |
| 9 | Spleen | 72.08 | Gold |
| 10 | Vermiform appendix | 71.58 | Gold |
| 11 | Duodenum | 68.35 | Gold |
| 12 | Gall bladder | 65.81 | Gold |
| 13 | Apex of heart | 63.92 | Gold |
| 14 | Smooth muscle tissue | 62.41 | Gold |
| 15 | Primordial germ cell (gonad) | 61.57 | Gold |
| 16 | Tonsil | 61.23 | Gold |
| 17 | Placenta | 60.86 | Gold |
| 18 | Rectum | 60.33 | Gold |
| 19 | Upper lobe of left lung | 59.23 | Gold |
| 20 | Metanephros cortex (kidney) | 59.03 | Gold |
| 21 | Small intestine | 58.30 | Gold |
| 22 | Islet of Langerhans | 58.08 | Gold |
| 23 | Peyer's patch | 57.98 | Gold |
| 24 | Skin of abdomen | 57.84 | Gold |
| 25 | Lung | 57.39 | Gold |
| 26 | Heart left ventricle | 57.27 | Gold |
| 27 | Omental fat pad | 57.27 | Gold |
| 28 | Right coronary artery | 56.43 | Gold |
| 29 | Transverse colon mucosa | 56.20 | Gold |
| 30 | Olfactory nasal mucosa | 56.13 | Gold |
Cell Type Expression Patterns
Highest expressing cell types:
- Granulocytes (immune cells)
- Monocytes (immune cells)
- Leukocytes (immune cells)
- Bone marrow cells
Expression pattern: TNF shows highest expression in immune cells, particularly myeloid lineage cells (granulocytes, monocytes), consistent with its role as a proinflammatory cytokine primarily
secreted by macrophages.
Single-Cell Expression Data
| Dataset ID | Description | Species | Cells |
|---|
| E-GEOD-106540 | Precursors of human CD4+ cytotoxic T lymphocytes | Homo sapiens | 2,244 |
Section 12: Disease Associations
OMIM Disease Association
| OMIM ID | Type |
|---|
| 191160 | Gene/Locus |
TNF has been implicated in: autoimmune diseases, insulin resistance, psoriasis, rheumatoid arthritis, ankylosing spondylitis, tuberculosis, autosomal dominant polycystic kidney disease, and cancer.
Mutations affect susceptibility to cerebral malaria, septic shock, and Alzheimer disease.
HPO Phenotype Associations
Total Phenotype Associations: 17
| HPO ID | Phenotype | Inheritance Pattern |
|---|
| HP:0000006 | Autosomal dominant inheritance | - |
| HP:0000007 | Autosomal recessive inheritance | - |
| HP:0001426 | Non-Mendelian inheritance | - |
| HP:0002077 | Migraine with aura | - |
| HP:0002083 | Migraine without aura | - |
| HP:0002099 | Asthma | - |
| HP:0000613 | Photophobia | - |
| HP:0002183 | Phonophobia | - |
| HP:0002013 | Vomiting | - |
| HP:0002018 | Nausea | - |
| HP:0002202 | Pleural effusion | - |
| HP:0010516 | Thymus hyperplasia | - |
| HP:0011462 | Young adult onset | - |
| HP:0031273 | Shock | - |
| HP:0032262 | Pulmonary tuberculosis | - |
| HP:0032933 | Airway hyperresponsiveness | - |
| HP:4000007 | Bronchoconstriction | - |
GWAS Associations
Total GWAS Associations: 28
| GWAS Study | Disease/Trait | Mapped Gene Region | P-value |
|---|
| GCST004133_30 | Ulcerative colitis | HLA-DQA1 | 5×10⁻⁶⁵ |
| GCST004131_25 | Inflammatory bowel disease | HLA-DQA1 | 2×10⁻³¹ |
| GCST008916_130 | Asthma | NFKBIL1 - LTA | 1×10⁻⁹ |
| GCST007269_18 | Pulse pressure | LTA - TNF | 8×10⁻¹⁹ |
| GCST000308_1 | AIDS progression | HCP5 | 3×10⁻¹⁹ |
| GCST004521_14 | Autism/schizophrenia | HCG27 - HLA-C | 3×10⁻¹⁷ |
| GCST008921_1 | Asthma + major depression | MICB | 2×10⁻¹⁶ |
| GCST004521_229 | Autism/schizophrenia | SFTA2 | 8×10⁻²⁰ |
| GCST004521_209 | Autism/schizophrenia | LINC02571 - HLA-B | 5×10⁻¹⁶ |
| GCST004521_211 | Autism/schizophrenia | HCP5, MICB-DT | 5×10⁻¹⁵ |
| GCST004521_53 | Autism/schizophrenia | LINC00243 | 2×10⁻¹⁵ |
| GCST004521_17 | Autism/schizophrenia | FGFR3P1 - ZDHHC20P2 | 3×10⁻¹⁵ |
| GCST004521_156 | Autism/schizophrenia | TSBP1-AS1 | 1×10⁻¹⁴ |
| GCST008916_32 | Asthma | HLA-B | 2×10⁻¹⁴ |
| GCST004521_265 | Autism/schizophrenia | PSORS1C1 | 7×10⁻¹⁴ |
| GCST004521_213 | Autism/schizophrenia | PPT2 | 5×10⁻¹³ |
| GCST012230_545 | Waist-to-hip ratio (BMI adj) | LTA - TNF | 3×10⁻¹² |
| GCST000879_48 | Crohn's disease | LTA - TNF | 4×10⁻¹¹ |
| GCST000738_5 | Neonatal lupus | HCP5, MICB-DT | 5×10⁻¹⁰ |
| GCST004521_76 | Autism/schizophrenia | TNXB | 2×10⁻¹⁰ |
| GCST008916_35 | Asthma | NFKBIL1 - LTA | 1×10⁻⁹ |
| GCST004521_188 | Autism/schizophrenia | RNU6-1133P - C6orf15 | 1×10⁻⁹ |
| GCST004833_9 | Cervical cancer | LTA | 6×10⁻⁹ |
| GCST011773_10 | Type 1 diabetes (age at diagnosis) | TNF | 3×10⁻⁷ |
| GCST008917_2 | Childhood onset asthma | MICB | 4×10⁻⁷ |
| GCST010725_71 | Malaria | MICB-DT, HCP5 | 5×10⁻⁷ |
| GCST002211_10 | Psychosis (atypical) | PRRC2A, SNORA38 | 4×10⁻⁶ |
| GCST010725_96 | Malaria | MICB-DT, HCP5 | 3×10⁻⁶ |
SUMMARY STATISTICS
| Category | Count |
|---|
| Gene Identifiers | 5 primary databases |
| Transcripts | 2 Ensembl, 1 MANE Select |
| Exons | 4 |
| Protein Entries | 1 reviewed UniProt |
| Protein Domains | 5 InterPro annotations |
| PDB Structures | 50 |
| Orthologs | Mouse, Rat (direct); Zebrafish, Fly (functional) |
| ClinVar Variants | 26 |
| SpliceAI Predictions | 205 |
| AlphaMissense Predictions | 1,498 |
| Reactome Pathways | 10 |
| GO Annotations | 193 |
| STRING Interactions | 10,273+ |
| IntAct Interactions | 212 |
| ESM2 Similar Proteins | 77 |
| DIAMOND Homologs | 54 |
| TF Regulators | 248 |
| Approved Drugs (Phase 4) | 5 small molecules + 5 biologics |
| PharmGKB Drug Associations | 32 |
| Bgee Tissue Profiles | 119 tissues |
| HPO Phenotypes | 17 |
| GWAS Associations | 28 |
This comprehensive reference document for human TNF covers all 12 requested sections with data from 70+ biological databases. Key highlights:
- TNF (HGNC:11892, ENSG00000232810) is located on chromosome 6p21.33 encoding a 233 amino acid proinflammatory cytokine
- 50 experimental PDB structures available, with the highest resolution at 1.358 Å
- 10,273+ protein interactions documented in STRING, with TNFRSF1A and TNFRSF1B as primary receptors
- 248 transcription factors regulate TNF expression, including NF-κB, AP-1, and multiple IRFs
- 5 approved small molecule drugs and 5 approved biologic TNF inhibitors (infliximab, etanercept, adalimumab, golimumab, certolizumab)
- Highest expression in immune cells (granulocytes, monocytes) consistent with its role in inflammation
- Associated with inflammatory bowel disease, asthma, rheumatoid arthritis, and other immune-mediated conditions